Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CLPT ClearPoint Neuro	$18.48 +2.9%	$12.98	$8.27 ▼ $30.10	$554.21M	1.31	997,538 shs	1.49 million shs
DCTH Delcath Systems	$12.94 +5.0%	$11.20	$8.12 ▼ $14.15	$446.71M	0.54	591,139 shs	1.41 million shs
GUTS Fractyl Health	$0.74 -7.0%	$0.76	$0.38 ▼ $2.45	$117.88M	2.34	1.72 million shs	1.53 million shs
KIDS OrthoPediatrics	$20.30 +3.5%	$17.60	$14.42 ▼ $23.70	$521.41M	1.03	140,049 shs	542,413 shs

7 Stocks to Buy And Hold Forever

Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CLPT ClearPoint Neuro	0.00%	+4.00%	+50.98%	+103.75%	+57.14%
DCTH Delcath Systems	0.00%	+10.69%	+18.17%	+44.26%	-7.17%
GUTS Fractyl Health	0.00%	-12.07%	-11.65%	+65.63%	-57.30%
KIDS OrthoPediatrics	0.00%	+7.58%	+13.98%	+30.80%	-5.97%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CLPT ClearPoint Neuro	$18.48 +2.9%	$12.98	$8.27 ▼ $30.10	$554.21M	1.31	997,538 shs	1.49 million shs
DCTH Delcath Systems	$12.94 +5.0%	$11.20	$8.12 ▼ $14.15	$446.71M	0.54	591,139 shs	1.41 million shs
GUTS Fractyl Health	$0.74 -7.0%	$0.76	$0.38 ▼ $2.45	$117.88M	2.34	1.72 million shs	1.53 million shs
KIDS OrthoPediatrics	$20.30 +3.5%	$17.60	$14.42 ▼ $23.70	$521.41M	1.03	140,049 shs	542,413 shs

7 Stocks to Buy And Hold Forever

Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CLPT ClearPoint Neuro	0.00%	+4.00%	+50.98%	+103.75%	+57.14%
DCTH Delcath Systems	0.00%	+10.69%	+18.17%	+44.26%	-7.17%
GUTS Fractyl Health	0.00%	-12.07%	-11.65%	+65.63%	-57.30%
KIDS OrthoPediatrics	0.00%	+7.58%	+13.98%	+30.80%	-5.97%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CLPT ClearPoint Neuro	2.33	Hold	$23.00	24.46% Upside
DCTH Delcath Systems	2.43	Hold	$22.50	73.88% Upside
GUTS Fractyl Health	2.40	Hold	$5.40	626.78% Upside
KIDS OrthoPediatrics	2.73	Moderate Buy	$24.44	20.42% Upside

Current Analyst Ratings Breakdown

Latest GUTS, CLPT, KIDS, and DCTH Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
6/18/2026	CLPT ClearPoint Neuro	B. Riley Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$20.00 ➝ $30.00
6/15/2026	KIDS OrthoPediatrics	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy
6/9/2026	CLPT ClearPoint Neuro	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$16.00
6/4/2026	GUTS Fractyl Health	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$8.00
5/12/2026	GUTS Fractyl Health	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
5/11/2026	DCTH Delcath Systems	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (D) ➝ Sell (D+)
5/11/2026	DCTH Delcath Systems	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Hold ➝ Strong Sell
5/8/2026	CLPT ClearPoint Neuro	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy	$16.00
5/1/2026	KIDS OrthoPediatrics	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$17.00
5/1/2026	KIDS OrthoPediatrics	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$24.00
4/24/2026	KIDS OrthoPediatrics	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$25.00

(Data available from 6/28/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CLPT ClearPoint Neuro	$36.97M	14.99	N/A	N/A	$0.99 per share	18.67
DCTH Delcath Systems	$85.23M	5.24	$0.05 per share	247.54	$3.15 per share	4.11
GUTS Fractyl Health	$90K	1,309.74	N/A	N/A	$0.07 per share	10.61
KIDS OrthoPediatrics	$236.35M	2.21	$0.17 per share	122.08	$13.82 per share	1.47

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CLPT ClearPoint Neuro	-$25.54M	-$1.01	N/A	N/A	N/A	-71.57%	-140.96%	-36.98%	8/11/2026 (Estimated)
DCTH Delcath Systems	$2.70M	$0.01	1,294.00	N/A	N/A	0.62%	0.51%	0.46%	8/5/2026 (Estimated)
GUTS Fractyl Health	-$140.95M	-$1.29	N/A	N/A	N/A	N/A	-4,053.15%	-96.41%	8/11/2026 (Estimated)
KIDS OrthoPediatrics	-$39.65M	-$1.68	N/A	N/A	N/A	-16.31%	-7.01%	-4.86%	8/4/2026 (Estimated)

Latest GUTS, CLPT, KIDS, and DCTH Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/13/2026	Q1 2026	CLPT ClearPoint Neuro	-$0.28	-$0.32	-$0.04	-$0.32	$11.97 million	$12.13 million
5/12/2026	Q1 2026	GUTS Fractyl Health	-$0.17	$0.06	+$0.23	$0.06	N/A	N/A
5/7/2026	Q1 2026	DCTH Delcath Systems	-$0.0971	-$0.03	+$0.0671	-$0.03	$23.51 million	$24.99 million
4/30/2026	Q1 2026	KIDS OrthoPediatrics	-$0.4552	-$0.42	+$0.0352	-$0.45	$58.29 million	$59.36 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
CLPT ClearPoint Neuro	N/A	N/A	N/A	N/A	N/A
DCTH Delcath Systems	N/A	N/A	N/A	N/A	N/A
GUTS Fractyl Health	N/A	N/A	N/A	N/A	N/A
KIDS OrthoPediatrics	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CLPT ClearPoint Neuro	2.63	5.79	4.88
DCTH Delcath Systems	N/A	11.24	10.33
GUTS Fractyl Health	1.41	4.28	4.28
KIDS OrthoPediatrics	0.29	5.21	2.37

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CLPT ClearPoint Neuro	30.08%
DCTH Delcath Systems	61.12%
GUTS Fractyl Health	N/A
KIDS OrthoPediatrics	69.05%

Insider Ownership

Company	Insider Ownership
CLPT ClearPoint Neuro	6.94%
DCTH Delcath Systems	19.36%
GUTS Fractyl Health	8.52%
KIDS OrthoPediatrics	31.80%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CLPT ClearPoint Neuro	110	29.99 million	27.91 million	Optionable
DCTH Delcath Systems	60	34.52 million	27.84 million	Optionable
GUTS Fractyl Health	102	158.65 million	145.13 million	N/A
KIDS OrthoPediatrics	200	25.68 million	17.52 million	Optionable

GUTS, CLPT, KIDS, and DCTH Headlines

Recent News About These Companies

OrthoPediatrics (KIDS) Stock Sees Split Analyst Revisions After Mixed Price Target Changes

June 25 at 3:55 PM | finance.yahoo.com

Analyzing Sight Sciences (NASDAQ:SGHT) and OrthoPediatrics (NASDAQ:KIDS)

June 25 at 5:27 AM | americanbankingnews.com

OSSIO Inc.’s Distribution Deal With OrthoPediatrics Corp. Brings Bio-Integrative, Metal-Free OSSIOfiber® Implants to U.S. Children’s Hospitals Nationwide

June 24, 2026 | finance.yahoo.com

OrthoPediatrics Unveils 2026 Investor Deck Highlighting Strategy

June 24, 2026 | theglobeandmail.com

OrthoPediatrics Announces Distribution Agreement with OSSIO, Inc. to Provide Revolutionary Orthopedic Fixation Technology to U.S. Children’s Hospitals Nationwide

June 24, 2026 | finance.yahoo.com

OrthoPediatrics Announces Distribution Agreement with OSSIO, Inc. to Provide Revolutionary Orthopedic Fixation Technology to U.S. Children's Hospitals Nationwide

June 24, 2026 | globenewswire.com

Financial Analysis: OrthoPediatrics (NASDAQ:KIDS) vs. Arrayit (OTCMKTS:ARYC)

June 17, 2026 | americanbankingnews.com

OrthoPediatrics (NASDAQ:KIDS) versus PAVmed (NASDAQ:PAVM) Financial Survey

June 17, 2026 | americanbankingnews.com

OrthoPediatrics Corp. (KIDS) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

June 8, 2026 | seekingalpha.com

Why The OrthoPediatrics (KIDS) Narrative Is Evolving Without A New Price Target

June 8, 2026 | finance.yahoo.com

A Look at OrthoPediatrics Corp (KIDS) After 4.1% Decline -- GF Value $33.82 vs Price $17.17

May 29, 2026 | gurufocus.com

OrthoPediatrics to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference

May 26, 2026 | globenewswire.com

How The OrthoPediatrics (KIDS) Story Is Shifting As Analysts Reassess Growth And Valuation

May 25, 2026 | finance.yahoo.com

Is the Selloff in OrthoPediatrics Corp. (KIDS) Creating a Buying Opportunity?

May 13, 2026 | insidermonkey.com

Is the Selloff in OrthoPediatrics Corp. (KIDS) Creating a Buying Opportunity?

May 13, 2026 | finance.yahoo.com

Canaccord Genuity Sticks to Its Buy Rating for OrthoPediatrics (KIDS)

May 6, 2026 | theglobeandmail.com

OrthoPediatrics raises 2026 revenue outlook to $263M-$267M while targeting free cash flow breakeven

May 1, 2026 | seekingalpha.com

OrthoPediatrics Corp (KIDS) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and ...

May 1, 2026 | finance.yahoo.com

OrthoPediatrics (KIDS) Q1 2026 Earnings Transcript

May 1, 2026 | finance.yahoo.com

OrthoPediatrics Corp. (KIDS) Q1 2026 Earnings Call Transcript

April 30, 2026 | seekingalpha.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

GUTS, CLPT, KIDS, and DCTH Company Descriptions

ClearPoint Neuro NASDAQ:CLPT

$18.48 +0.52 (+2.90%)

Closing price 06/26/2026 04:00 PM Eastern

Extended Trading

$18.40 -0.08 (-0.43%)

As of 06/26/2026 07:41 PM Eastern

ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.V., UCB Biopharma SRL, and University of California and San Francisco; and development and license agreement with NE Scientific, LLC. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.

Delcath Systems NASDAQ:DCTH

$12.94 +0.62 (+5.03%)

Closing price 06/26/2026 04:00 PM Eastern

Extended Trading

$12.88 -0.06 (-0.50%)

As of 06/26/2026 07:33 PM Eastern

Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO is the FOCUS clinical trial for patients with metastatic hepatic dominant Uveal Melanoma to investigate objective response rate in metastatic uveal melanoma. It also provides HEPZATO as a stand-alone medical device under the CHEMOSAT Hepatic Delivery System trade name for Melphalan or CHEMOSAT for medical centers to treat a range of liver cancers in Europe. Delcath Systems, Inc. was incorporated in 1988 and is headquartered in New York, New York.

Fractyl Health NASDAQ:GUTS

$0.74 -0.06 (-7.00%)

Closing price 06/26/2026 04:00 PM Eastern

Extended Trading

$0.77 +0.03 (+3.50%)

As of 06/26/2026 07:48 PM Eastern

Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. It also develops Rejuva, a novel adeno-associated virus delivered pancreatic gene therapy platform that is designed to enable long-term remission of T2D and obesity by durably altering metabolic hormone function in the pancreatic islet cells of patients. Fractyl Health, Inc. was formerly known as Fractyl Laboratories Inc. and changed its name to Fractyl Health, Inc. on June 09, 2021. The company was incorporated in 2010 and is headquartered in Burlington, Massachusetts.

OrthoPediatrics NASDAQ:KIDS

$20.30 +0.68 (+3.47%)

Closing price 06/26/2026 04:00 PM Eastern

Extended Trading

$20.50 +0.20 (+0.99%)

As of 06/26/2026 07:43 PM Eastern

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediguard, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIMTM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIROTM Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, and Mitchell Ponseti. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest GUTS, CLPT, KIDS, and DCTH Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest GUTS, CLPT, KIDS, and DCTH Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

GUTS, CLPT, KIDS, and DCTH Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

GUTS, CLPT, KIDS, and DCTH Company Descriptions

ClearPoint Neuro NASDAQ:CLPT

Delcath Systems NASDAQ:DCTH

Fractyl Health NASDAQ:GUTS

OrthoPediatrics NASDAQ:KIDS

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest GUTS, CLPT, KIDS, and DCTH Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest GUTS, CLPT, KIDS, and DCTH Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

GUTS, CLPT, KIDS, and DCTH Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

GUTS, CLPT, KIDS, and DCTH Company Descriptions

ClearPoint Neuro NASDAQ:CLPT

Delcath Systems NASDAQ:DCTH

Fractyl Health NASDAQ:GUTS

OrthoPediatrics NASDAQ:KIDS

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools